Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited)

v3.25.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2023 $ 706,415 $ (232) $ (600,658) $ 105,525
Balance, at beginning (in shares) at Dec. 31, 2023 20,926        
Issuance of common stock upon exercise of prefunded common warrants
Issuance of common stock upon exercise of prefunded common warrants (in shares) 4,701        
Fair value of warrants reclassified from liabilities to equity 15,850 15,850
Employee stock purchase plan 23 23
Employee stock purchase plan (in shares) 21        
Stock-based compensation 1,692 1,692
Foreign currency translation loss (8) (8)
Net loss (14,939) (14,939)
Ending balance, value at Mar. 31, 2024 723,980 (240) (615,597) 108,143
Balance, at end (in shares) at Mar. 31, 2024 25,648        
Beginning balance, value at Dec. 31, 2024 $ 4 870,503 (255) (730,694) 139,558
Balance, at beginning (in shares) at Dec. 31, 2024 4,385,929        
Repurchase of common stock under share repurchase program, including transactional expenses of $8 (3,047) (3,047)
Repurchase of common stock under share repurchase program, including transactional expenses of $8 (in shares) (250,000)        
Issuance of common stock under At-the-Market, net of transactional expenses of $2,182 $ 3 59,840 59,843
Issuance of common stock under At-the-Market, net of transactional expenses of $2,182 (in shares) 2,741,887        
Stock-based compensation 882 882
Foreign currency translation loss (11) (11)
Net loss (16,829) (16,829)
Ending balance, value at Mar. 31, 2025 $ 7 $ 928,178 $ (266) $ (747,523) $ 180,396
Balance, at end (in shares) at Mar. 31, 2025 6,877,816